BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18452019)

  • 1. Design and synthesis of biotinylated inositol phosphates relevant to the biotin-avidin techniques.
    Anraku K; Inoue T; Sugimoto K; Morii T; Mori Y; Okamoto Y; Otsuka M
    Org Biomol Chem; 2008 May; 6(10):1822-30. PubMed ID: 18452019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of biotinylated inositol 1,3,4,5-tetrakisphosphate targeting Grp1 pleckstrin homology domain.
    Anraku K; Inoue T; Sugimoto K; Kudo K; Okamoto Y; Morii T; Mori Y; Otsuka M
    Bioorg Med Chem; 2011 Nov; 19(22):6833-41. PubMed ID: 21996606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avidin-biotin system: a small library of cysteine biotinylated derivatives designed for the [99mTc(N)(PNP)]2+ metal fragment.
    Bolzati C; Caporale A; Agostini S; Carta D; Cavazza-Ceccato M; Refosco F; Tisato F; Schievano E; Bandoli G
    Nucl Med Biol; 2007 Jul; 34(5):511-22. PubMed ID: 17591551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioconjugation of biotinylated PAMAM dendrons to avidin.
    Tao L; Geng J; Chen G; Xu Y; Ladmiral V; Mantovani G; Haddleton DM
    Chem Commun (Camb); 2007 Sep; (33):3441-3. PubMed ID: 17700875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-assisted total synthesis of the optical antipodes D-myo-inositol 3,4,5-trisphosphate and D-myo-inositol 1,5, 6-trisphosphate: aspects of their structure-activity relationship to biologically active inositol phosphates.
    Adelt S; Plettenburg O; Stricker R; Reiser G; Altenbach HJ; Vogel G
    J Med Chem; 1999 Apr; 42(7):1262-73. PubMed ID: 10197969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisection of biotinylated soft spherical structures.
    Joshi KB; Verma S
    Biophys Chem; 2009 Mar; 140(1-3):129-32. PubMed ID: 19117661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized avidin nucleic acid nanoassemblies by a tailored PEGylation strategy and their application as molecular amplifiers in detection.
    Pignatto M; Realdon N; Morpurgo M
    Bioconjug Chem; 2010 Jul; 21(7):1254-63. PubMed ID: 20527874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible biofunctionalization of surfaces with a switchable mutant of avidin.
    Pollheimer P; Taskinen B; Scherfler A; Gusenkov S; Creus M; Wiesauer P; Zauner D; Schöfberger W; Schwarzinger C; Ebner A; Tampé R; Stutz H; Hytönen VP; Gruber HJ
    Bioconjug Chem; 2013 Oct; 24(10):1656-68. PubMed ID: 23978112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desymmetrization of 4,6-diprotected myo-inositol.
    Lauber MB; Daniliuc CG; Paradies J
    Chem Commun (Camb); 2013 Aug; 49(67):7409-11. PubMed ID: 23860461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FT-IRRAS spectroscopic studies of the interaction of avidin with biotinylated dendrimer surfaces.
    Liu Z; Amiridis MD
    Colloids Surf B Biointerfaces; 2004 Jun; 35(3-4):197-203. PubMed ID: 15261032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new biotinylated tris bipyridinyl iron(II) complex as redox biotin-bridge for the construction of supramolecular biosensing architectures.
    Haddour N; Gondran C; Cosnier S
    Chem Commun (Camb); 2004 Feb; (3):324-5. PubMed ID: 14740059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein supramolecular complex formation by site-specific avidin-biotin interactions.
    Mori Y; Wakabayashi R; Goto M; Kamiya N
    Org Biomol Chem; 2013 Feb; 11(6):914-22. PubMed ID: 23104386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric detection of biotinylated peptides captured by avidin functional affinity electrophoresis.
    Lee BS; Krisnanchettiar S; Lateef SS; Gupta S
    Rapid Commun Mass Spectrom; 2005; 19(7):886-92. PubMed ID: 15726549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotransmitter analog tethered to a silicon platform for neuro-BioMEMS applications.
    Nehilla BJ; Popat KC; Vu TQ; Chowdhury S; Standaert RF; Pepperberg DR; Desai TA
    Biotechnol Bioeng; 2004 Sep; 87(5):669-74. PubMed ID: 15352065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of NADPH-cytochrome P450 reductase antisense oligos using avidin-biotin approach.
    Pillai VC; Yesudas R; Shaik IH; Thekkumkara TJ; Bickel U; Srivenugopal KS; Mehvar R
    Bioconjug Chem; 2010 Feb; 21(2):203-7. PubMed ID: 20063878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotinylation reagents for the study of cell surface proteins.
    Elia G
    Proteomics; 2008 Oct; 8(19):4012-24. PubMed ID: 18763706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the interaction of the biotin-avidin complex with the relaxivity of biotinylated Gd-DTPA.
    Langereis S; Kooistra HA; van Genderen MH; Meijer EW
    Org Biomol Chem; 2004 May; 2(9):1271-3. PubMed ID: 15105914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotin derivatives carrying two chelating DOTA units. Synthesis, in vitro evaluation of biotinidases resistance, avidin binding, and radiolabeling tests.
    Pratesi A; Bucelli F; Mori I; Chinol M; Verdoliva A; Paganelli G; Rivieccio V; Gariboldi L; Ginanneschi M
    J Med Chem; 2010 Jan; 53(1):432-40. PubMed ID: 19928962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of rhenium(I) polypyridine biotin complexes as a new class of luminescent probes for avidin.
    Lo KK; Hui WK
    Inorg Chem; 2005 Mar; 44(6):1992-2002. PubMed ID: 15762726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotin binding.
    Hoya K; Guterman LR; Miskolczi L; Hopkins LN
    Drug Deliv; 2001; 8(4):215-22. PubMed ID: 11757779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.